By Defending Potti, Duke Officials Become Target Of Charges Of Institutional Failure
Duke Officials Decline To Provide Details Of Probe
Biostatisticians Write To Varmus Asking NCI To Investigate
The Lancet Oncology Issues “Expression Of Concern” Over Paper
Duke Insiders Allege Intimidation By Administration
Also in this issue: ODAC Votes To Strip Breast Cancer Indication From Avastin
Trending Stories
- Columbia’s cancer center becomes collateral damage in Trump’s war on antisemitism
- What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - Caught in the crossfire: The critical threats facing cancer centers, research, and patient care
- Kennedy announces massive cuts, centralization at HHS—NCI and FDA hit
Also this week: Columbia yields, Makary and Bhattacharya confirmed, tariffs on pharmaceuticals, and more changes impacting oncology - Pediatric cancer research cut from spending legislation at last minute
Republicans quietly removed hard-won pediatric cancer bills - DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated